Приклади вживання Lassa fever Англійська мовою та їх переклад на Українською
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
The Mano River Union Lassa Fever Network.
Lassa fever occurs in all age groups and both sexes.
There is currently no vaccine that protects against Lassa fever.
In Nigeria spreads Lassa fever: from disease died 70 people.
Lassa fever is suspected in 1708 people and 472 people is laboratory confirmed.
Following delivery,women should receive the same treatment as other Lassa fever patients.
Lassa fever, on the other hand, is carried and transmitted by the Natal Multimammate Mouse.
On rare occasions, travellers from areas where Lassa fever is endemic export the disease to other countries.
Lassa fever is a zoonotic disease, meaning that humans become infected from contact with infected animals.
Though first described in the 1950s, the virus causing Lassa fever disease was not identified until 1969.
The most recent Lassa fever outbreak in Benin occurred in the same area in January- May 2016.
Our DNA shows evidence forrecent selection for resistance of killer diseases like Lassa fever and malaria.
Lassa fever is an acute viral haemorrhagic illness of 1-4 weeks duration that occurs in West Africa.
Health authorities in Benin, Burkina Faso andTogo are implementing the following measures to respond to these Lassa fever cases, including:.
Lassa fever is described as an acute viral haemorrhagic illness of one to four weeks duration that occurs in West Africa.
The antiviral drugribavirin seems to be an effective treatment for Lassa fever if given early on in the course of clinical illness.
Lassa fever is difficult to distinguish from other viral haemorrhagic fevers such as Ebola virus disease;
Health workers are at risk if caring for Lassa fever patients in the absence of proper barrier nursing and infection control practices.
Lassa fever, on the other hand, is carried by the Natal Multimammate Mouse, which is indigenous to most of Sub-Saharan Africa.
In addition, a new ward dedicated to the care of patients with Lassa fever is under construction in Sierra Leone, sponsored by the European Union.
Lassa fever is an acute viral haemorrhagic illness caused by Lassa virus, a member of the arenavirus family of viruses.
Health care workers are at risk if caring for Lassa fever patients in the absence of appropriate infection prevention and control measures.
The programme supports these three countries in developing national prevention strategies andenhancing laboratory diagnostics for Lassa fever and other dangerous diseases.
Tags: Lassa Fever, Lassa fever is an acute viral haemorrhagic illness of 1-4 weeks duration that occurs in West Africa.
Workers seeing a patient suspected to have Lassa fever should immediately contact local and national experts for advice and to arrange for laboratory testing.
Lassa fever is known to be endemic in Benin(where it was diagnosed for the first time in November 2014), Guinea, Liberia, Sierra Leone and parts of Nigeria, but probably exists in other West African countries as well.
Although other tropical infections are much more common, the diagnosis of Lassa fever should be considered in febrile patients returning from West Africa, especiallyif they have had exposures in rural areas or hospitals in countries where Lassa fever is known to be endemic.